These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21818751)
1. Assessment of mitochondrial toxicity in HepG2 cells cultured in high-glucose- or galactose-containing media. Swiss R; Will Y Curr Protoc Toxicol; 2011 Aug; Chapter 2():Unit2.20. PubMed ID: 21818751 [TBL] [Abstract][Full Text] [Related]
2. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Marroquin LD; Hynes J; Dykens JA; Jamieson JD; Will Y Toxicol Sci; 2007 Jun; 97(2):539-47. PubMed ID: 17361016 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial membrane potential measurement of H9c2 cells grown in high-glucose and galactose-containing media does not provide additional predictivity towards mitochondrial assessment. Rana P; Nadanaciva S; Will Y Toxicol In Vitro; 2011 Mar; 25(2):580-7. PubMed ID: 21126567 [TBL] [Abstract][Full Text] [Related]
4. Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Dott W; Mistry P; Wright J; Cain K; Herbert KE Redox Biol; 2014; 2():224-33. PubMed ID: 24494197 [TBL] [Abstract][Full Text] [Related]
5. Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the Xu Q; Liu L; Vu H; Kuhls M; Aslamkhan AG; Liaw A; Yu Y; Kaczor A; Ruth M; Wei C; Imredy J; Lebron J; Pearson K; Gonzalez R; Mitra K; Sistare FD Chem Res Toxicol; 2019 Aug; 32(8):1528-1544. PubMed ID: 31271030 [TBL] [Abstract][Full Text] [Related]
6. Acute Metabolic Switch Assay Using Glucose/Galactose Medium in HepaRG Cells to Detect Mitochondrial Toxicity. Kamalian L; Douglas O; Jolly CE; Snoeys J; Simic D; Monshouwer M; Williams DP; Park BK; Chadwick AE Curr Protoc Toxicol; 2019 Jun; 80(1):e76. PubMed ID: 31058461 [TBL] [Abstract][Full Text] [Related]
8. A combined in vitro approach to improve the prediction of mitochondrial toxicants. Eakins J; Bauch C; Woodhouse H; Park B; Bevan S; Dilworth C; Walker P Toxicol In Vitro; 2016 Aug; 34():161-170. PubMed ID: 27083147 [TBL] [Abstract][Full Text] [Related]
9. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Rana P; Anson B; Engle S; Will Y Toxicol Sci; 2012 Nov; 130(1):117-31. PubMed ID: 22843568 [TBL] [Abstract][Full Text] [Related]
11. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved. Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584 [TBL] [Abstract][Full Text] [Related]
12. A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays. Hynes J; Nadanaciva S; Swiss R; Carey C; Kirwan S; Will Y Toxicol In Vitro; 2013 Mar; 27(2):560-9. PubMed ID: 23147640 [TBL] [Abstract][Full Text] [Related]
13. Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants. Delp J; Funke M; Rudolf F; Cediel A; Bennekou SH; van der Stel W; Carta G; Jennings P; Toma C; Gardner I; van de Water B; Forsby A; Leist M Arch Toxicol; 2019 Jun; 93(6):1585-1608. PubMed ID: 31190196 [TBL] [Abstract][Full Text] [Related]
14. Global changes to HepG2 cell metabolism in response to galactose treatment. Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction induced by leflunomide and its active metabolite. Xuan J; Ren Z; Qing T; Couch L; Shi L; Tolleson WH; Guo L Toxicology; 2018 Mar; 396-397():33-45. PubMed ID: 29427785 [TBL] [Abstract][Full Text] [Related]
16. A systematic assessment of mitochondrial function identified novel signatures for drug-induced mitochondrial disruption in cells. Li N; Oquendo E; Capaldi RA; Robinson JP; He YD; Hamadeh HK; Afshari CA; Lightfoot-Dunn R; Narayanan PK Toxicol Sci; 2014 Nov; 142(1):261-73. PubMed ID: 25163676 [TBL] [Abstract][Full Text] [Related]
17. Modulation of cellular energetics by galactose and pioglitazone. Grimm D; Altamirano L; Paudel S; Welker L; Konkle ME; Chakraborty N; Menze MA Cell Tissue Res; 2017 Sep; 369(3):641-646. PubMed ID: 28776185 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of in Vitro Mitochondrial Toxicity Assays and Physicochemical Properties for Prediction of Organ Toxicity Using 228 Pharmaceutical Drugs. Rana P; Aleo MD; Gosink M; Will Y Chem Res Toxicol; 2019 Jan; 32(1):156-167. PubMed ID: 30525499 [TBL] [Abstract][Full Text] [Related]
19. Use of Primary Rat Hepatocytes for Prediction of Drug-Induced Mitochondrial Dysfunction. Liu C; Sekine S; Song B; Ito K Curr Protoc Toxicol; 2017 May; 72():14.16.1-14.16.10. PubMed ID: 28463418 [TBL] [Abstract][Full Text] [Related]
20. Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin riboside. Orlicka-Płocka M; Gurda-Wozna D; Fedoruk-Wyszomirska A; Wyszko E Apoptosis; 2020 Dec; 25(11-12):835-852. PubMed ID: 32955614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]